SLC17A6.md
... ...
@@ -18,14 +18,8 @@ nocite: |
18 18
19 19
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
20 20
21
-|Entity|source |frequency (%)|
22
-|:------:|:----:|:----:|
23
-|BL|GAMBL Exome |1.724 |
24
-|BL|GAMBL Genome |1.158 |
25
-|DLBCL|GAMBL Exome |1.456 |
26
-|DLBCL|GAMBL Genome |1.316 |
27
-|MCL|GAMBL Genome |0.585 |
28
-
21
+### MCL
22
+[[include:tables/MCL_SLC17A6]]
29 23
30 24
[[include:tables/mermaid_SLC17A6.md]]
31 25
SMARCB1.md
... ...
@@ -14,9 +14,8 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:-------------:|:-------------:|
19
-|MCL |GAMBL genomes|1.9 |
17
+### MCL
18
+[[include:tables/MCL_SMARCB1]]
20 19
21 20
## Mutation pattern and selective pressure estimates
22 21
SMC1A.md
... ...
@@ -14,9 +14,8 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:-------------:|:-------------:|
19
-|MCL |GAMBL genomes|0 |
17
+### MCL
18
+[[include:tables/MCL_SMC1A]]
20 19
21 20
## Mutation pattern and selective pressure estimates
22 21
TBC1D26.md
... ...
@@ -14,9 +14,8 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:-------------:|:-------------:|
19
-|MCL |GAMBL genomes|0 |
17
+### MCL
18
+[[include:tables/MCL_TBC1D26]]
20 19
21 20
## Mutation pattern and selective pressure estimates
22 21
TNRC6B.md
... ...
@@ -18,15 +18,8 @@ nocite: |
18 18
19 19
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
20 20
21
-|Entity|source |frequency (%)|
22
-|:------:|:----:|:----:|
23
-|BL|GAMBL Exome |6.322 |
24
-|BL|GAMBL Genome |1.544 |
25
-|DLBCL|GAMBL Exome |2.426 |
26
-|DLBCL|GAMBL Genome |2.632 |
27
-|FL|GAMBL Exome |0.86 |
28
-|MCL|GAMBL Genome |0.585 |
29
-
21
+### MCL
22
+[[include:tables/MCL_TNRC6B]]
30 23
31 24
[[include:tables/mermaid_TNRC6B.md]]
32 25
TRPM6.md
... ...
@@ -18,15 +18,9 @@ nocite: |
18 18
19 19
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
20 20
21
-|Entity|source |frequency (%)|
22
-|:------:|:----:|:----:|
23
-|BL|GAMBL Exome |6.897 |
24
-|BL|GAMBL Genome |2.703 |
25
-|DLBCL|GAMBL Exome |3.342 |
26
-|DLBCL|GAMBL Genome |2.068 |
27
-|FL|GAMBL Exome |1.146 |
28
-|MCL|GAMBL Genome |2.924 |
21
+### MCL
29 22
23
+[[include:tables/MCL_TRPM6]]
30 24
31 25
[[include:tables/mermaid_TRPM6.md]]
32 26
ZNF117.md
... ...
@@ -14,9 +14,8 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:-------------:|:-------------:|
19
-|MCL |GAMBL genomes|0 |
17
+### MCL
18
+[[include:tables/MCL_ZNF117]]
20 19
21 20
## Mutation pattern and selective pressure estimates
22 21